title: Effectiveness of crosstrimester test in selecting high-risk pregnant women to undergo invasive prenatal diagnosis.
authors.forename: Paolo
authors.initials: P
authors.lastname: Guanciali-Franchi
authors.forename: Irene
authors.initials: I
authors.lastname: Iezzi
authors.forename: Barbara
authors.initials: B
authors.lastname: Matarrelli
authors.forename: Elisena
authors.initials: E
authors.lastname: Morizio
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Calabrese
authors.forename: Giandomenico
authors.initials: G
authors.lastname: Palka
mesh_terms: D000328:Adult; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D004314:Down Syndrome / Q000097:blood / Q000175:diagnosis* / Q000000981:diagnostic imaging; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D048208:Nuchal Translucency Measurement; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011266:Pregnancy-Associated Plasma Protein-A / Q000032:analysis; D011296:Prenatal Diagnosis / Q000191:economics / Q000379:methods*; D016216:Ultrasonography, Prenatal
chemical_list: D018997:Chorionic Gonadotropin, beta Subunit, Human; D011266:Pregnancy-Associated Plasma Protein-A